From the Research
Teriparatide (Forteo) does not have a direct, significant impact on kidney function, but its effects on the kidneys are not well-studied in the provided evidence. The provided studies do not directly address the effects of teriparatide on the kidneys. However, we can consider the general principles of medication effects on kidney function.
- Medications that are primarily cleared through renal excretion may require dose adjustments in patients with kidney disease.
- Medications that have a significant impact on blood pressure or fluid status may also affect kidney function.
- Patients with existing kidney disease should be monitored closely when starting new medications, especially those that may affect kidney function.
The most recent and highest quality study provided is from 2023 1, but it does not address teriparatide or its effects on the kidneys.
- This study discusses the prognostic implications of urinary potassium to creatinine ratio in patients with predialysis chronic kidney disease.
- It highlights the importance of monitoring kidney function and electrolyte levels in patients with kidney disease.
Other studies provided discuss the effects of different medications on kidney function, such as levetiracetam 2, thiazide diuretics 3, 4, and telmisartan 5.
- These studies suggest that certain medications may have beneficial or harmful effects on kidney function, depending on the specific medication and patient population.
- However, they do not provide direct evidence about the effects of teriparatide on the kidneys.
In clinical practice, it is essential to monitor kidney function and electrolyte levels in patients with kidney disease who are starting new medications, including teriparatide.
- Patients should be advised to maintain adequate hydration and report any changes in urine output or electrolyte levels.
- Healthcare providers should be aware of the potential effects of medications on kidney function and adjust treatment plans accordingly.